Structural comparison of suberanilohydroxamic acid (SAHA) and other zinc-enzyme inhibitors bound to a monomeric zinc species

Zinc Enzyme Inhibitors

10.1007/978-3-319-46112-0 ◽

2017 ◽

Cited By ~ 1

Keyword(s):

Enzyme Inhibitors ◽

Zinc Enzyme

Download Full-text

Drug Design of Zinc-Enzyme Inhibitors

10.1002/9780470508169 ◽

2009 ◽

Cited By ~ 42

Keyword(s):

Drug Design ◽

Enzyme Inhibitors ◽

Zinc Enzyme

Download Full-text

3644 Pleiotropic effect of angiotensin-converting enzyme inhibitors on MMP-9: a key enzyme in cardiac and vascular remodelling

European Heart Journal ◽

10.1016/s0195-668x(03)96228-2 ◽

2003 ◽

Vol 24 (5) ◽

pp. 711

Author(s):

D REINHARDT

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Pleiotropic Effect ◽

Converting Enzyme ◽

Vascular Remodelling ◽

Converting Enzyme Inhibitors ◽

Key Enzyme

Download Full-text

Irbesartan Combined With Conventional Therapy, Including Angiotensin Converting Enzyme Inhibitors, in Heart Failure

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(97)84523-8 ◽

1998 ◽

Vol 31 (2) ◽

pp. 188A ◽

Cited By ~ 4

Author(s):

M Tonkon

Keyword(s):

Heart Failure ◽

Angiotensin Converting Enzyme ◽

Conventional Therapy ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Spectrophotometric Determination of Some Angiotensin Converting Enzyme Inhibitors By Potassium Dichromate and Potassium Permanganate in Tablet Dosage Form

Asian Journal of Biomedical and Pharmaceutical Sciences ◽

10.15272/ajbps.v4i39.642 ◽

2014 ◽

Vol 4 (39) ◽

pp. 16-24 ◽

Cited By ~ 2

Author(s):

Horria A. Mohamed

Keyword(s):

Angiotensin Converting Enzyme ◽

Potassium Permanganate ◽

Dosage Form ◽

Enzyme Inhibitors ◽

Potassium Dichromate ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Tablet Dosage

Download Full-text

Nephroprotective therapy with angiotensin converting enzyme inhibitors effect evaluation on the course of chronic kidney disease in children with urinary system congenital malformations

Nephrology (Saint-Petersburg) ◽

10.24884/1561-6274-2019-23-3-59-64 ◽

2019 ◽

Vol 23 (3) ◽

pp. 59-64

Author(s):

A. M. Mambetova ◽

A. M. Inarokova ◽

N. N. Shabalova ◽

D. V. Bizheva ◽

M. K. Mokaeva ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Angiotensin Converting Enzyme ◽

Congenital Malformations ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Urinary System ◽

Converting Enzyme ◽

Effect Evaluation ◽

Converting Enzyme Inhibitors

Download Full-text

Reactions induced by angiotensin-converting enzyme inhibitors – etiopathogenic, clinical and therapeutic aspects

Alergologia ◽

10.26416/aler.1.1.2017.1240 ◽

2017 ◽

Vol 1 (1) ◽

Cited By ~ 2

Author(s):

Polliana Mihaela Leru

Keyword(s):

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

Effect of angiotensin-converting enzyme inhibitors on response to erythropoietin in chronic renal failure patients

MedPulse International Journal of Pharmacology ◽

10.26611/10101312 ◽

2020 ◽

Vol 13 (1) ◽

pp. 05-09

Author(s):

A Vinoth Kumar ◽

◽

P KalaiSelvi ◽

Keyword(s):

Renal Failure ◽

Chronic Renal Failure ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors

Download Full-text

A FUZZY LOGIC APPROACH FOR STRUCTURAL COMPARISON, RATING, AND FINDING DISTINCT INVERSIONS OF KINEMATIC CHAINS

i-manager’s Journal on Future Engineering and Technology ◽

10.26634/jfet.12.2.10367 ◽

2017 ◽

Vol 12 (2) ◽

pp. 16

Author(s):

RAO V. SRINIVASA ◽

RAO K. MALLIKARJUNA ◽

RAO A.B. SRINIVASA ◽

◽

...

Keyword(s):

Fuzzy Logic ◽

Structural Comparison ◽

Kinematic Chains ◽

Fuzzy Logic Approach ◽

Logic Approach

Download Full-text

Faculty Opinions recommendation of Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090740.552962 ◽

2007 ◽

Author(s):

Carl Erik Mogensen

Keyword(s):

Kidney Disease ◽

Angiotensin Converting Enzyme ◽

Treatment Effects ◽

Enzyme Inhibitors ◽

Angiotensin Converting Enzyme Inhibitors ◽

Urinary Protein Excretion ◽

Converting Enzyme ◽

Converting Enzyme Inhibitors ◽

Protein Excretion ◽

Progression Risk

Download Full-text